[DOI] [PubMed] [Google Scholar] 28.Ruijgrok C, Blaak EE, Egli L, Dussort P, Vinoy S, Rauh SP, Beulens JW, Robertson MD, Alssema M
A 2021 analysis published in Cardiovascular Diabetology found that semaglutide produced significant reductions in triglycerides and total cholesterol alongside its weight loss effects, with improvements correlating strongly with the degree of weight lost (Husain et al., Cardiovascular Diabetology, 2021, Tirzepatide and Cholesterol: Does the Dual Mechanism Help More For patients with significant lipid abnormalities, tirzepatide may offer an advantage over semaglutide
Armazenamento: Conservar ao abrigo da luz, calor e umidade
These can include: Hypersensitivity or allergic reactions Nausea, vomiting, or diarrhea Headaches or dizziness Joint pain or stiffness A flushing sensation after injection It is important to note that these risks are rare and usually mild